Detalhe da pesquisa
1.
Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials.
Liver Int
; 34(5): 707-19, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24118703